HUMAN HEALTH TECHNOLOGIES LTDActive

Company number 09120946Private limited companyIncorporated 2014

Key figures

£1,824,740+332.0%
Net assets 2024
+59.7%
Average annual growth 2019–2024
-1 m01 m2 m2019202020232024

Like most small UK companies, HUMAN HEALTH TECHNOLOGIES LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m2019202020232024
Filed accounts2019–2024
2019202020232024
Cash at bank and in hand1338654,2442,501
Total assets1,499,8172,128,4522,311,031—
Total liabilities1,051,9801,811,8203,097,530—
Net assets / total equity447,837316,632-786,4991,824,740
Average number of employees1130

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2024

The principal activity of the company is that of development in biotechnology.

As described in the company's latest filed accounts.

Summary: HUMAN HEALTH TECHNOLOGIES LTD

Company

HUMAN HEALTH TECHNOLOGIES LTD is a private limited company registered with Companies House under company number 09120946. It was incorporated on 8 Jul 2014. Its status is active. The registered office is in Newport (NP10). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files small company accounts (filleted). Net assets were £1,824,740, up 332% on the previous year. Cash at bank and in hand was £2,501. The company had an average of 0 employees. Figures are available for 4 financial years (2019–2024).

Control and charges

One person with significant control is registered. 2 of 2 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 11 Jul 2027.